Detalhe da pesquisa
1.
Extracellular vesicles as a liquid biopsy for melanoma: Are we there yet?
Semin Cancer Biol
; 89: 92-98, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706847
2.
Detection of clinical progression through plasma ctDNA in metastatic melanoma patients: a comparison to radiological progression.
Br J Cancer
; 126(3): 401-408, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34373567
3.
First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.
Cancer Immunol Immunother
; 71(2): 417-431, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34216247
4.
Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report.
BMC Cancer
; 19(1): 1109, 2019 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727009
5.
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients.
BMC Cancer
; 18(1): 726, 2018 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29986670
6.
Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT).
Clin Lung Cancer
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38705835
7.
Brief Report: Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma-RIOMeso.
J Thorac Oncol
; 19(4): 636-642, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036250
8.
First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study.
Front Oncol
; 14: 1305720, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38406805
9.
Detectable ctDNA at the time of treatment cessation of ipilimumab and nivolumab for toxicity predicts disease progression in advanced melanoma patients.
Front Oncol
; 13: 1280730, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38179171
10.
LOREALAUS: LOrlatinib REAL-World AUStralian Experience in Advanced ALK-Rearranged NSCLC.
JTO Clin Res Rep
; 4(4): 100490, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37077199
11.
BRAF inhibitor cessation prior to disease progression in metastatic melanoma: Long-term outcomes.
Eur J Cancer
; 179: 87-97, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509002
12.
Long-term outcomes and persistent toxicities following BRAF/MEK inhibitor therapy for advanced melanoma.
Eur J Cancer
; 194: 113354, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827067
13.
Associations of Physical Activity and Exercise with Health-related Outcomes in Patients with Melanoma During and After Treatment: A Systematic Review.
Integr Cancer Ther
; 20: 15347354211040757, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34412527
14.
Intra- and intertumoral heterogeneity of liver metastases in a patient with uveal melanoma revealed by single-cell RNA sequencing.
Cold Spring Harb Mol Case Stud
; 7(5)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34470851
15.
Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancer.
Cancer Treat Res Commun
; 28: 100405, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34329846
16.
Circulating Tumour DNA in Advanced Melanoma Patients Ceasing PD1 Inhibition in the Absence of Disease Progression.
Cancers (Basel)
; 12(11)2020 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33238616
17.
The Prognostic Impact of Circulating Tumour DNA in Melanoma Patients Treated with Systemic Therapies-Beyond BRAF Mutant Detection.
Cancers (Basel)
; 12(12)2020 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33339135
18.
Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy.
Clin Cancer Res
; 26(22): 5926-5933, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33067256
19.
Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma.
Asia Pac J Clin Oncol
; 15(1): 26-30, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30426665
20.
Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma.
Mol Oncol
; 13(2): 171-184, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30312528